These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32811625)

  • 41. Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study.
    Sorkhou M; Rabin RA; Rabin JS; Kloiber S; McIntyre RS; George TP
    Am J Addict; 2022 Sep; 31(5):454-462. PubMed ID: 35690891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction and Cessation of Alcohol, Cannabis, and Stimulant Use: Prospective Associations With Changes in Depressive Symptoms Across Two Cohort Studies of Sexual and Gender Minorities.
    Dyar C; Bradley H; Morgan E; Sullivan PS; Mustanski B
    J Stud Alcohol Drugs; 2020 Nov; 81(6):790-797. PubMed ID: 33308409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depression symptoms associated with cannabis dependence in an adolescent American Indian community sample.
    Gilder DA; Ehlers CL
    Am J Addict; 2012; 21(6):536-43. PubMed ID: 23082832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of cannabis use and clinical correlates among individuals with Major Depressive Disorder and Bipolar Disorder.
    Taub S; Feingold D; Rehm J; Lev-Ran S
    Compr Psychiatry; 2018 Jan; 80():89-96. PubMed ID: 29069624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Negative symptoms as key features of depression among cannabis users: a preliminary report.
    Bersani G; Bersani FS; Caroti E; Russo P; Albano G; Valeriani G; Imperatori C; Minichino A; Manuali G; Corazza O
    Eur Rev Med Pharmacol Sci; 2016; 20(3):547-52. PubMed ID: 26914132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley JD
    Psychiatr Clin North Am; 2023 Dec; 46(4):775-788. PubMed ID: 37879838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene.
    Otten R; Engels RC
    Addict Biol; 2013 Sep; 18(5):826-35. PubMed ID: 21967091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. White matter fractional anisotropy over two time points in early onset schizophrenia and adolescent cannabis use disorder: A naturalistic diffusion tensor imaging study.
    Epstein KA; Kumra S
    Psychiatry Res; 2015 Apr; 232(1):34-41. PubMed ID: 25779033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership.
    Cooke ME; Potter KW; Jashinski J; Pascale M; Schuster RM; Tervo-Clemmens B; Hoeppner BB; Pachas GN; Evins AE; Gilman JM
    Front Psychiatry; 2023; 14():1083334. PubMed ID: 36960460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabis and Depression.
    Feingold D; Weinstein A
    Adv Exp Med Biol; 2021; 1264():67-80. PubMed ID: 33332004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy.
    Kay-Lambkin FJ; Baker AL; Lewin TJ; Carr VJ
    Addiction; 2009 Mar; 104(3):378-88. PubMed ID: 19207345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.
    Borodovsky JT; Sofis MJ; Sherman BJ; Gray KM; Budney AJ
    Psychol Addict Behav; 2022 Aug; 36(5):515-525. PubMed ID: 35084903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of cannabis use disorder on post-traumatic stress disorder symptoms, depression symptoms, and non-suicidal self-injury among college students.
    Blessing A; Russell PD; DeBeer BB; Kimbrel NA; Meyer EC; Morissette SB
    J Am Coll Health; 2023 Jan; ():1-5. PubMed ID: 36595655
    [No Abstract]   [Full Text] [Related]  

  • 57. Between- and within-group effects of alcohol and cannabis co-use on AUD/CUD in the NSDUH 2002-2019.
    Waddell JT
    Drug Alcohol Depend; 2021 Aug; 225():108768. PubMed ID: 34049100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of a brief distress intolerance intervention on acute stress modulation of response inhibition neurophysiology in cannabis use disorder.
    Afshar K; Cougle JR; Schmidt NB; Macatee RJ
    Addict Behav; 2023 Dec; 147():107811. PubMed ID: 37517377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Developmental pathways from prenatal marijuana exposure to Cannabis Use Disorder in young adulthood.
    Sonon K; Richardson GA; Cornelius J; Kim KH; Day NL
    Neurotoxicol Teratol; 2016; 58():46-52. PubMed ID: 27208888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Goal commitment evolution in a Spanish adolescent sample with cannabis use disorder.
    Matalí JL; Pérez-Racana A; Flores E; Lleras M; Goti J; Kaminer Y
    Addict Behav; 2020 Aug; 107():106388. PubMed ID: 32208323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.